Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

FTSE 100 hits one-month low, precious miners biggest drag

Published 16/01/2024, 08:25
Updated 16/01/2024, 17:36
© Reuters. Signage for the London Stock Exchange Group is seen outside of offices in Canary Wharf in London, Britain, August 3, 2023. REUTERS/Toby Melville/File Photo

By Sruthi Shankar and Khushi Singh

(Reuters) -London's blue-chip FTSE 100 index closed lower on Tuesday, hitting a one-month low, weighed down by a sell-off in precious metal mining shares, while hawkish remarks from central bankers outweighed support from better-than-expected UK wages data.

The FTSE 100 dropped 0.5%, while the domestically focussed FTSE 250 index was flat.

Precious metal miners led sectoral declines with a 2.6% fall, as gold prices dipped on a stronger dollar and rise in U.S. Treasury yields amid uncertainty around early interest rate cuts. [GOL/]

Global investors have scaled back expectations of aggressive monetary policy easing following better-than-expected economic data, particularly out of the United States.

"The rate cut conundrum continues to leave investors scratching their heads, wondering when central banks are going to stop backpedalling after giving hints about cuts," said Danni Hewson, head of financial analysis at AJ Bell.

European Central Bank officials also warned on Monday it was too early to discuss rate cuts.

That countered optimism from data that showed British wages grew at the slowest pace in almost a year, adding to signs of a gradual cooling of inflationary pressure in the labour market.

Among individual stocks, shares in Superdry tumbled 11.6%, hitting a record low, on a report that the fashion retailer has hired PwC to examine further debt-raising options.

Experian gained 2.4% after the credit data firm posted a 9% rise in its third-quarter revenue, powered by strong demand for its new products and business wins.

UK's largest property portal Rightmove Plc (LON:RMV) dropped 3.9% after JP Morgan downgraded the stock to "underweight".

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

AstraZeneca (NASDAQ:AZN) shares lost 1.9%, after UBS initiated coverage on the drugmaker stock with "sell", flagging concerns about its exposure to U.S. Medicare Part D reform that may result in price pressures and sales growth decrease.

The broader pharma and biotech index was down 1.2%.

Supporting the mid-cap index, Qinetiq gained 4.5% after the defence group launched a 100 million-pound ($126.54 million) share buyback programme.

($1 = 0.7903 pound)

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.